CUE (Cue Biopharma, Inc.) Stock Market Reviews

crown

search

Read and share opinions on CUE (Cue Biopharma, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

CUE

Cue Biopharma, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments
Nov 13, 2025
Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates
Nov 12, 2025
Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Nov 12, 2025
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
Nov 6, 2025
Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates
Sep 29, 2025
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference
Aug 21, 2025
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
Aug 13, 2025
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
Aug 12, 2025
Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Aug 12, 2025
Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
Jul 16, 2025
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
Jul 1, 2025
Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
Jun 24, 2025
Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates
May 12, 2025
Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 12, 2025

Reviews